Pharmabiz

Indian pharmaceutical market clocked 10.7% growth in August driven by price realization & Mounjaro surge

Indian pharmaceutical market clocked 10.7% growth in August driven by price realization & Mounjaro surge: Peethaambaran Kunnathoor, Chennai Wednesday, September 9, 2026, 08:00 Hrs ...
Pharmabiz

Expert asks NPPA to fix ceiling price for two early-stage breast cancer drugs abemaciclib and ribociclib

Expert asks NPPA to fix ceiling price for two early-stage breast cancer drugs abemaciclib and ribociclib: Our Bureau, New Delhi Wednesday, September 9, 2026, 08:00 Hrs [IST] The C ...
Pharmabiz

Fire safety must be embedded in healthcare design, not treated as an afterthought: Experts at FSIE 2026

Fire safety must be embedded in healthcare design, not treated as an afterthought: Experts at FSIE 2026: Shardul Nautiyal, Mumbai Wednesday, September 9, 2026, 08:00 Hrs [IST] Fir ...
Pharmabiz

Panel asks health ministry to mandate systematic pharmacoeconomic studies for widely prescribed Ayush drugs

The Department-related Parliamentary Standing Committee on Health and Family Welfare has recommended to the ministry of health to mandate systematic pharmacoeconomic studies for all widely prescribed ...
Pharmabiz

India’s speciality pharma push to depend on scientific innovation and effective manufacturing processes

India’s speciality pharma push to depend on scientific innovation and effective manufacturing processes: Nandita Vijayasimha, Bengaluru Wednesday, September 9, 2026, 08:00 Hrs [ ...
Pharmabiz

Leucine Rich Bio launches enhanced BugSpeaks Skin Microbiome Test 2026 Edition

Leucine Rich Bio launches enhanced BugSpeaks Skin Microbiome Test 2026 Edition: Our Bureau, Bengaluru Wednesday, September 9, 2026, 10:00 Hrs [IST] Leucine Rich Bio, South Asia’ ...
Pharmabiz

Novartis phase III HARBOR study of delpacibart etedesiran to treat myotonic dystrophy type 1 fails to meet primary endpoint

Novartis phase III HARBOR study of delpacibart etedesiran to treat myotonic dystrophy type 1 fails to meet primary endpoint: Basel Wednesday, September 9, 2026, 09:00 Hrs [IST] No ...
Opinion
PharmabizOpinion

A LAUDABLE INITIATIVE ON AMR

Obviously, it is a well thought out initiative as drug resistance cannot not be solved by guidelines alone. It can be solved at the patient's bedside, one clinical decision at a time. Those decisions ...
Pharmabiz

Clover Biopharma announces positive phase 2 data for RSV + hMPV ± PIV3 respiratory combination vaccine candidates in older adults

In parallel with the Phase 2 trial, Clover conducted commercial-scale 2,000L bioreactor scale-up production of multiple batches of Trimer-Tagged RSV, hMPV and PIV3 PreF antigen components of ...
Pharmabiz

Sun Pharmaceutical assigned preliminary 'BBB+' rating with stable Outlook: S&P Global Ratings

Sun Pharmaceutical assigned preliminary 'BBB+' rating with stable Outlook: S&P Global Ratings: Our Bureau, Mumbai Tuesday, September 8, 2026, 17:50 Hrs [IST] S&P Global Ratings as ...
Pharmabiz

BMJ Research Forum South Asia 2026 calls for research that changes lives

BMJ Research Forum South Asia 2026, was held in New Delhi under the theme “Driving Real-World Impact from Health Research in ...
Pharmabiz

Indian healthcare providers are moving AI from pilots to practice: Bain & Company and HealthQuad

Indian healthcare providers are moving AI from pilots to practice: Bain & Company and HealthQuad: Our Bureau, Mumbai Tuesday, September 8, 2026, 17:30 Hrs [IST] Bain & Company and ...